Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

BCc1, the novel antineoplastic nanocomplex, showed potent anticancer effects in vitro and in vivo.

Kalanaky S, Hafizi M, Fakharzadeh S, Vasei M, Langroudi L, Janzamin E, Hashemi SM, Khayamzadeh M, Soleimani M, Akbari ME, Nazaran MH.

Drug Des Devel Ther. 2015 Dec 30;10:59-70. doi: 10.2147/DDDT.S89694. eCollection 2016.

2.

A porphyrin-PEG polymer with rapid renal clearance.

Huang H, Hernandez R, Geng J, Sun H, Song W, Chen F, Graves SA, Nickles RJ, Cheng C, Cai W, Lovell JF.

Biomaterials. 2016 Jan;76:25-32. doi: 10.1016/j.biomaterials.2015.10.049. Epub 2015 Oct 21.

PMID:
26517562
3.

Serum protein adsorption and excretion pathways of metal nanoparticles.

Vinluan RD 3rd, Zheng J.

Nanomedicine (Lond). 2015 Sep;10(17):2781-94. doi: 10.2217/nnm.15.97. Epub 2015 Sep 10.

PMID:
26377047
4.

Ubiquitin Urine Levels in Burn Patients.

Wong YM, LaPorte HM, Albee LJ, Baker TA, Bach HH 4th, Vana PG, Evans AE, Gamelli RL, Majetschak M.

J Burn Care Res. 2015 Jul 21. [Epub ahead of print]

PMID:
26204385
5.

Stealth filaments: Polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X.

Lee KL, Shukla S, Wu M, Ayat NR, El Sanadi CE, Wen AM, Edelbrock JF, Pokorski JK, Commandeur U, Dubyak GR, Steinmetz NF.

Acta Biomater. 2015 Jun;19:166-79. doi: 10.1016/j.actbio.2015.03.001. Epub 2015 Mar 10.

PMID:
25769228
6.

Therapeutic aptamers: developmental potential as anticancer drugs.

Lee JW, Kim HJ, Heo K.

BMB Rep. 2015 Apr;48(4):234-7. Review.

7.

Fibrillous carbon nanotube: an unexpected journey.

McDevitt MR, Scheinberg DA.

Crit Rev Oncog. 2014;19(3-4):261-8. Review.

8.

Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy.

Kaittanis C, Shaffer TM, Thorek DL, Grimm J.

Crit Rev Oncog. 2014;19(3-4):143-76. Review.

9.

Synthesis, pharmacokinetics, and biological use of lysine-modified single-walled carbon nanotubes.

Mulvey JJ, Feinberg EN, Alidori S, McDevitt MR, Heller DA, Scheinberg DA.

Int J Nanomedicine. 2014 Sep 4;9:4245-55. doi: 10.2147/IJN.S66050. eCollection 2014. Erratum in: Int J Nanomedicine. 2015;10:595.

10.

Megalin-mediated specific uptake of chitosan/siRNA nanoparticles in mouse kidney proximal tubule epithelial cells enables AQP1 gene silencing.

Gao S, Hein S, Dagnæs-Hansen F, Weyer K, Yang C, Nielsen R, Christensen EI, Fenton RA, Kjems J.

Theranostics. 2014 Aug 13;4(10):1039-51. doi: 10.7150/thno.7866. eCollection 2014.

11.

Using 2-photon microscopy to understand albuminuria.

Molitoris BA.

Trans Am Clin Climatol Assoc. 2014;125:343-56; discussion 356-7. Review.

12.

Stealth nanotubes: strategies of shielding carbon nanotubes to evade opsonization and improve biodistribution.

Kotagiri N, Kim JW.

Int J Nanomedicine. 2014 May 6;9 Suppl 1:85-105. doi: 10.2147/IJN.S51854. eCollection 2014. Review.

13.

Bimodal imaging probes for combined PET and OI: recent developments and future directions for hybrid agent development.

Seibold U, Wängler B, Schirrmacher R, Wängler C.

Biomed Res Int. 2014;2014:153741. doi: 10.1155/2014/153741. Epub 2014 Apr 16. Review.

14.

Rational design of "heat seeking" drug loaded polypeptide nanoparticles that thermally target solid tumors.

McDaniel JR, MacEwan SR, Li X, Radford DC, Landon CD, Dewhirst M, Chilkoti A.

Nano Lett. 2014 May 14;14(5):2890-5. doi: 10.1021/nl5009376. Epub 2014 Apr 21.

15.

Targeted delivery system of nanobiomaterials in anticancer therapy: from cells to clinics.

Jin SE, Jin HE, Hong SS.

Biomed Res Int. 2014;2014:814208. doi: 10.1155/2014/814208. Epub 2014 Feb 19. Review.

16.

The proximal tubule and albuminuria: really!

Dickson LE, Wagner MC, Sandoval RM, Molitoris BA.

J Am Soc Nephrol. 2014 Mar;25(3):443-53. doi: 10.1681/ASN.2013090950. Epub 2014 Jan 9. Review.

17.

Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.

Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC.

Adv Drug Deliv Rev. 2014 Feb;66:2-25. doi: 10.1016/j.addr.2013.11.009. Epub 2013 Nov 22. Review.

18.

Strategies for advancing cancer nanomedicine.

Chauhan VP, Jain RK.

Nat Mater. 2013 Nov;12(11):958-62. doi: 10.1038/nmat3792. No abstract available.

19.

Self-assembly of carbon nanotubes and antibodies on tumours for targeted amplified delivery.

Mulvey JJ, Villa CH, McDevitt MR, Escorcia FE, Casey E, Scheinberg DA.

Nat Nanotechnol. 2013 Oct;8(10):763-71. doi: 10.1038/nnano.2013.190. Epub 2013 Sep 29.

20.

Carbon nanotubes in hyperthermia therapy.

Singh R, Torti SV.

Adv Drug Deliv Rev. 2013 Dec;65(15):2045-60. doi: 10.1016/j.addr.2013.08.001. Epub 2013 Aug 8. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk